My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Bajaj Finance gets revision in credit ratings
Jun 06,2017

Bajaj Finance announced that ICRA has upgraded credit rating of the Company for NCDs and subordinated debt as follows -

Non Convertible Debentures - ICRA AAA / Stable ( Revised from ICRA AA+/ Positive)

Subordinated Debt - ICRA AAA / Stable (Revised from ICRA AA+/ Positive)

ICRA has reaffirmed the Commercial Paper Programme rating at ICRA A1+ and for Fixed Deposits Programme rating at MAAA/ Stable.

Powered by Capital Market - Live News

Asian Paints slips after bulk deal
Jun 06,2017

Meanwhile, the S&P BSE Sensex was down 10.08 points, or 0.03% to 31,299.41

Bulk deal boosted volume on the scrip. On the BSE, 3.94 lakh shares were traded in the counter so far, compared with average daily volumes of 1.16 lakh shares in the past one quarter. The stock had hit a high of Rs 1,166.30 and a low of Rs 1,141.45 so far during the day. The stock hit a record high of Rs 1,230 on 13 October 2016. The stock hit a 52-week low of Rs 850.10 on 22 December 2016.

The stock had underperformed the market over the past one month till 5 June 2017, rising 1.38% compared with 4.86% rise in the Sensex. The scrip, however, outperformed the market in past one quarter, rising 13.61% as against Sensexs 7.97% rise. The scrip had also underperformed the market in past one year, gaining 13.36% as against Sensexs 16.92% rise.

The large-cap company has equity capital of Rs 95.92 crore. Face value per share is Re 1.

Asian Paints consolidated net profit rose 10.14% to Rs 479.61 crore on 8.3% rise in total income to Rs 4022.56 crore in Q4 March 2017 over Q4 March 2016.

Asian Paints is Indias leading paint company and ranked among the top ten decorative coatings companies in the world.

Powered by Capital Market - Live News

Tata Elxsi spurts over 15% in two sessions
Jun 06,2017

The announcement was made during trading hours yesterday, 5 June 2017. Shares of Tata Elxsi rose 9.81% to settle at Rs 1,491.70 yesterday, 5 June 2017. The stock has risen 15.36% in two trading sessions from its close of Rs 1,358.40 on Friday, 2 June 2017.

Meanwhile, the S&P BSE Sensex was up 2.73 points, or 0.01% to 31,312.22.

On the BSE, 2.69 lakh shares were traded in the counter so far, compared with average daily volumes of 47,495 shares in the past one quarter. The stock had hit a high of Rs 1,598 and a low of Rs 1,496.55 so far during the day. The stock hit a 52-week high of Rs 1,827 on 9 June 2016. The stock hit a 52-week low of Rs 1,021.65 on 21 November 2016.

The stock had underperformed the market over the past one month till 5 June 2017, falling 3.31% compared with 4.86% rise in the Sensex. The scrip had also underperformed the market in past one quarter, rising 2.35% as against Sensexs 7.97% rise. The scrip had also underperformed the market in past one year, falling 16.02% as against Sensexs 16.92% rise.

The mid-cap company has equity capital of Rs 31.14 crore. Face value per share is Rs 10.

Tata Elxsi announced the licensing of its advanced autonomous vehicle middleware platform AUTONOMAI to one of the worlds top 5 automotive OEMs (original equipment manufacturers) for their driverless car R&D (research and development).

The Autonomai platform provides carmakers and Tier 1 automotive suppliers with a comprehensive and modular solution covering perception, GNC (guidance navigation control) and drive-by-wire systems, to quickly build, test and deploy autonomous vehicles.

This solution supports sensor fusion with a variety of sensors from cameras to radar and lidar, and leverages sophisticated artificial intelligence (AI) and deep learning based algorithms to deliver the complex use-case scenarios expected of driverless cars.

Autonomai also allows rapid region specific adaptation through its pre-integrated validation datasets and AI & deep learning capabilities.

Net profit of Tata Elxsi rose 8.30% to Rs 44.50 crore on 10.92% rise in net sales to Rs 326.05 crore in Q4 March 2017 over Q4 March 2016.

Tata Elxsi is a global design and technology services company, headquartered in Bangalore.

Powered by Capital Market - Live News

Precious metals shine
Jun 06,2017

Bullion prices ended higher at Comex on Monday, 05 June 2017. Gold prices scored a second-straight session of gains on Monday, holding ground at a six-week high as global markets absorbed weekend terrorist attacks in London and investors awaited the outcome of the European Central Bank meeting and U.K. general election later this week.

August gold rose $2.50, or 0.2%, to settle at $1,282.70 an ounce. July silver rose 5.6 cents, or 0.3%, to $17.581 an ounce.

U.S. economic data released Monday were mixed, with a government report showing that the productivity of American companies and their employees was unchanged in the first three months of this year, instead of declining at a 0.6% annual rate.

The Institute for Supply Management said its non manufacturing index fell 0.6 points to 56.9% in May, while the Commerce Department reported that factory orders dipped 0.2% in April.

Powered by Capital Market - Live News

Gufic Biosciences jumps after receiving two patent certificates
Jun 06,2017

The announcement was made after market hours yesterday, 5 June 2017.

Meanwhile, the S&P BSE Sensex was up 13.64 points, or 0.04% at 31,323.13. The S&P BSE Small-Cap index was up 9.65 points, or 0.06% at 15,419.60.

On the BSE, 1.51 lakh shares were traded on the counter so far as against the average daily volume of 3.41 lakh shares in the past one quarter. The stock had hit a high of Rs 73.75 and a low of Rs 71.25 so far during the day. The stock had hit a record high of Rs 77.40 on 18 May 2017 and hit a 52-week low of Rs 33.30 on 29 September 2016.

The stock had underperformed the market over the past one month till 5 June 2017, advancing 4.74% compared with the Sensexs 4.86% rise. The scrip had, however, outperformed the market over the past one quarter advancing 22.3% as against the Sensexs 8.59% rise. The scrip had also outperformed the market over the past one year advancing 66.79% as against the Sensexs 16.64% rise.

The small-cap company has equity capital of Rs 7.74 crore. Face value per share is Rs 1.

Gufic Biosciences said that it has received two patent certificates from the Intellectual Property India, the Government of India, granting patents to the company for the formulation of a freeze dried pharmaceutical composition and process for preparation i.e. process for preparation of parental formulation of Anidulafungin and the second formulation is a freeze dried parental composition of Tigecycline and process for preparation.

The company is in the process of applying the above patents in other countries, as well.

Gufic Biosciences net profit rose 40.5% to Rs 3.12 crore on 13% increase in net sales to Rs 64.51 crore in Q4 March 2017 over Q4 March 2016.

Gufic Biosciences is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products.

Powered by Capital Market - Live News

BEML opens 40 acre Environment-Park
Jun 06,2017

BEML has opened Environment-Park at its KGF Complex. The park is spread over 40 acres. The park will have various facilities like jogging pathways, two water bodies and variety of plants. The park will also provide solar lighting, bio toilet and will promote other eco-friendly activities.

Powered by Capital Market - Live News

Metalyst Forgings to hold board meeting
Jun 06,2017

Metalyst Forgings will hold a meeting of the Board of Directors of the Company on 10 June 2017.

Powered by Capital Market - Live News

VJTF Eduservices to hold board meeting
Jun 06,2017

VJTF Eduservices will hold a meeting of the Board of Directors of the Company on 12 June 2017.

Powered by Capital Market - Live News

Castex Technologies to hold board meeting
Jun 06,2017

Castex Technologies will hold a meeting of the Board of Directors of the Company on 10 June 2017.

Powered by Capital Market - Live News

Adani Enterprises spurts after final approval for Australia coal mine project
Jun 06,2017

The announcement was made during trading hours today, 6 June 2017.

Meanwhile, the S&P BSE Sensex was up 1.61 points, or 0.01% to 31,311.10.

On the BSE, 13,000 shares were traded in the counter so far, compared with average daily volumes of 17.59 lakh shares in the past one quarter. The stock had hit a high of Rs 124.80 and a low of Rs 118.80 so far during the day. The stock hit a 52-week high of Rs 160.60 on 18 April 2017. The stock hit a 52-week low of Rs 58.35 on 9 November 2016.

The stock had outperformed the market over the past one month till 5 June 2017, rising 3.79% compared with 4.86% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 20.17% as against Sensexs 7.97% rise. The scrip had also outperformed the market in past one year, rising 63.18% as against Sensexs 16.92% rise.

The large-cap company has equity capital of Rs 109.98 crore. Face value per share is Re 1.

Adani Enterprises gave final investment approval on Tuesday, 6 June 2017, for its Carmichael coal mine and railway in Australias north.

Adani Chairman, Gautam Adani, announced the official start of one of the largest single infrastructure developments in Australias recent history. This is the largest single investment by an Indian corporation in Australia. The company has been challenged by activists in the courts, in inner city streets, and even outside banks that have not even been approached to finance the project. The company is still facing activists. But it is committed to this project, Gautam Adani said.

Adani has signed contracts for design, construction, operations, supply of materials and professional services.

The Carmichael mine has faced years of delays amid opposition from environment groups who argue it will contribute to global warming and damage the Great Barrier Reef, leading some banks to rule out any role in funding. The project is located in the remote Galilee Basin, a 247,000 square-kilometre (95,000 square mile) expanse in the central outback that some believe has the potential to become Australias largest coal-producing region.

On a consolidated basis, net profit of Adani Enterprises rose 72.31% to Rs 218.80 crore on 49.61% rise in net sales to Rs 12195.15 crore in Q4 March 2017 over Q4 March 2016.

Adani Enterprises is the flagship entity of the Adani group. Adani Enterprises started as a trading firm dealing in myriad commodities. Over a period of time, coal became its main stay and after it emerged as Indias leading coal importer, it made forays into multiple sectors as forward and backward integration.

Powered by Capital Market - Live News

Adani Enterprises spurts after final OK for coal mine project
Jun 06,2017

The announcement was made during trading hours today, 6 June 2017.

Meanwhile, the S&P BSE Sensex was up 1.61 points, or 0.01% to 31,311.10.

On the BSE, 13,000 shares were traded in the counter so far, compared with average daily volumes of 17.59 lakh shares in the past one quarter. The stock had hit a high of Rs 124.80 and a low of Rs 118.80 so far during the day. The stock hit a 52-week high of Rs 160.60 on 18 April 2017. The stock hit a 52-week low of Rs 58.35 on 9 November 2016.

The stock had outperformed the market over the past one month till 5 June 2017, rising 3.79% compared with 4.86% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 20.17% as against Sensexs 7.97% rise. The scrip had also outperformed the market in past one year, rising 63.18% as against Sensexs 16.92% rise.

The large-cap company has equity capital of Rs 109.98 crore. Face value per share is Re 1.

Adani Enterprises gave final investment approval on Tuesday, 6 June 2017, for its Carmichael coal mine and railway in Australias north.

Adani Chairman, Gautam Adani, announced the official start of one of the largest single infrastructure developments in Australias recent history. This is the largest single investment by an Indian corporation in Australia. The company has been challenged by activists in the courts, in inner city streets, and even outside banks that have not even been approached to finance the project. The company is still facing activists. But it is committed to this project, Gautam Adani said.

Adani has signed contracts for design, construction, operations, supply of materials and professional services.

The Carmichael mine has faced years of delays amid opposition from environment groups who argue it will contribute to global warming and damage the Great Barrier Reef, leading some banks to rule out any role in funding. The project is located in the remote Galilee Basin, a 247,000 square-kilometre (95,000 square mile) expanse in the central outback that some believe has the potential to become Australias largest coal-producing region.

On a consolidated basis, net profit of Adani Enterprises rose 72.31% to Rs 218.80 crore on 49.61% rise in net sales to Rs 12195.15 crore in Q4 March 2017 over Q4 March 2016.

Adani Enterprises is the flagship entity of the Adani group. Adani Enterprises started as a trading firm dealing in myriad commodities. Over a period of time, coal became its main stay and after it emerged as Indias leading coal importer, it made forays into multiple sectors as forward and backward integration.

Powered by Capital Market - Live News

IRB Infra slips ex-dividend
Jun 06,2017

Meanwhile, the S&P BSE Sensex was down 34.41 points or 0.11% at 31,275.05. The S&P BSE Mid-Cap index was down 33.33 points or 0.22% at 14,790.73.

On the BSE, 41,000 shares were traded on the counter so far as against the average daily volumes of 3.23 lakh shares in the past one quarter. The stock had hit a high of Rs 234.25 and a low of Rs 230 so far during the day. It had hit a 52-week high of Rs 272.40 on 3 May 2017 and a 52-week low of Rs 177.50 on 23 November 2016.

The mid-cap company has equity capital of Rs 351.45 crore. Face value per share is Rs 10.

Before turning ex-dividend, the IRB Infrastructure Developers stock offered a dividend yield of 1.28% based on its closing price of Rs 234.25 on the BSE yesterday, 5 June 2017.

On a consolidated basis, IRB Infrastructure Developers net profit rose 32.15% to Rs 207.23 crore on 5.89% growth in net sales to Rs 1627.12 crore in Q4 March 2017 over Q4 March 2016.

IRB Infrastructure Developers is one of the largest private roads and highways infrastructure developers in India.

Powered by Capital Market - Live News

Green light for Adanis Carmicheal mine and rail project in Central Queensland
Jun 06,2017

Adani Chairman Gautam Adani on 6 June 2017 has given green light for the Carmicheal mine and rail project in Central Queensland. He said the Carmicheal projects will generate 10,000 direct and indirect jobs with pre construction works starting in the September quarter 2017.

Australian Head of Country and Chief Excutive, Jeyukumar Janakaraj, said the company had already invested $3.3 billion in the project including buying bulk coal handling port at port of Abbot Point.

Adani signed contracts for design, construction, operations, supply of materials and professional services. The biggest worth $2.6 billion is with Downer Mining for the construction and operation of the Carmicheal mine.

The Company also announced in the past few weeks contracts totalling more than $150 million for railway tracks and concrete sleepers for the planned 388 kilometre standard gauge rail link between the mine and Abbot Point.

Powered by Capital Market - Live News

Cadila Healthcare jumps after getting EIR for Baddi facility
Jun 06,2017

Meanwhile, the S&P BSE Sensex was up 52.43 points, or 0.17% to 31,361.92.

On the BSE, 67,000 shares were traded in the counter so far, compared with average daily volumes of 1.21 lakh shares in the past one quarter. The stock had hit a high of Rs 510 so far during the day, which is also a record high for the counter. The stock had hit a low of Rs 501 so far during the day. The stock hit a 52-week low of Rs 305.05 on 24 June 2016.

The stock had outperformed the market over the past one month till 5 June 2017, rising 5.26% compared with 4.86% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 12.58% as against Sensexs 7.97% rise. The scrip had also outperformed the market in past one year, rising 51.93% as against Sensexs 16.92% rise.

The large-cap company has equity capital of Rs 102.37 crore. Face value per share is Re 1.

Cadila Healthcare announced after market hours yesterday, 5 June 2017, that its formulations manufacturing facility at Baddi in Himachal Pradesh has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA). This receipt of EIR indicates the successful closure of the inspection points (483s) raised based on the inspection carried out between 21 February 2017 to 1 March 2017.

Cadila Healthcares consolidated net profit fell 32.2% to Rs 385.5 crore on 6.5% rise in net sales to Rs 2417.50 crore in Q4 March 2017 over Q4 March 2016.

Cadila Healthcare is a global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

Powered by Capital Market - Live News

Cadila Healthcare jumps after getting inspection report for Baddi facility
Jun 06,2017

Meanwhile, the S&P BSE Sensex was up 52.43 points, or 0.17% to 31,361.92.

On the BSE, 67,000 shares were traded in the counter so far, compared with average daily volumes of 1.21 lakh shares in the past one quarter. The stock had hit a high of Rs 510 so far during the day, which is also a record high for the counter. The stock had hit a low of Rs 501 so far during the day. The stock hit a 52-week low of Rs 305.05 on 24 June 2016.

The stock had outperformed the market over the past one month till 5 June 2017, rising 5.26% compared with 4.86% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 12.58% as against Sensexs 7.97% rise. The scrip had also outperformed the market in past one year, rising 51.93% as against Sensexs 16.92% rise.

The large-cap company has equity capital of Rs 102.37 crore. Face value per share is Re 1.

Cadila Healthcare announced after market hours yesterday, 5 June 2017, that its formulations manufacturing facility at Baddi in Himachal Pradesh has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA). This receipt of EIR indicates the successful closure of the inspection points (483s) raised based on the inspection carried out between 21 February 2017 to 1 March 2017.

Cadila Healthcares consolidated net profit fell 32.2% to Rs 385.5 crore on 6.5% rise in net sales to Rs 2417.50 crore in Q4 March 2017 over Q4 March 2016.

Cadila Healthcare is a global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

Powered by Capital Market - Live News